...
机译:设计基于短肽的HIV-1融合抑制剂的有效结合策略
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing, 100850, China;
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016, China;
MOH Key Laboratory of Systems Biology of Pathogens and AIDS Research Center, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 9, Dong Dan San Tiao, Beijing 100730, China;
Sc hool of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016, China;
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing, 100850, China;
MOH Key Laboratory of Systems Biology of Pathogens and AIDS Research Center, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 9, Dong Dan San Tiao, Beijing 100730, China;
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing, 100850, China;
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing, 100850, China;
机译:新型Apaf-1抑制剂与基于肽的细胞膜转运蛋白的缀合:改善抑制线粒体介导的细胞凋亡的有效方法。
机译:将人工尾标加入基于肽的HIV-1融合剂,以改善其效力和电阻曲线
机译:包含M-T钩结构的基于人工肽的HIV-1融合抑制剂,具有增强的抗病毒效力和耐药性
机译:针对HIV-1 gp41的肽融合抑制剂的开发
机译:评价PRO 2000,CS,T-PSS,PMHS和SAMMA作为HIV-1 Env诱导的依赖CD4的细胞融合的抑制剂。
机译:具有两个尾锚和棕榈酸的基于肽的HIV-1融合抑制剂可显着改善体内和体外的抗HIV-1活性并延长体内半衰期
机译:将人工尾锚添加到基于肽的HIV-1融合抑制剂中以提高其效力和抗性谱